These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36749855)

  • 1. Improvement of the Metabolic Stability of GPR88 Agonist RTI-13951-33: Design, Synthesis, and Biological Evaluation.
    Rahman MT; Decker AM; Ben Hamida S; Perrey DA; Chaminda Lakmal HH; Maitra R; Darcq E; Kieffer BL; Jin C
    J Med Chem; 2023 Feb; 66(4):2964-2978. PubMed ID: 36749855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The GPR88 agonist RTI-13951-33 reduces alcohol drinking and seeking in mice.
    Ben Hamida S; Carter M; Darcq E; Sourty M; Rahman MT; Decker AM; Jin C; Kieffer BL
    Addict Biol; 2022 Nov; 27(6):e13227. PubMed ID: 36301207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of a Potent, Selective, and Brain-Penetrant Small Molecule that Activates the Orphan Receptor GPR88 and Reduces Alcohol Intake.
    Jin C; Decker AM; Makhijani VH; Besheer J; Darcq E; Kieffer BL; Maitra R
    J Med Chem; 2018 Aug; 61(15):6748-6758. PubMed ID: 30011199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and pharmacological validation of a novel radioligand for the orphan GPR88 receptor.
    Decker AM; Rahman MT; Kormos CM; Hesk D; Darcq E; Kieffer BL; Jin C
    Bioorg Med Chem Lett; 2023 Jan; 80():129120. PubMed ID: 36587872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, Synthesis, and Structure-Activity Relationship Studies of (4-Alkoxyphenyl)glycinamides and Bioisosteric 1,3,4-Oxadiazoles as GPR88 Agonists.
    Rahman MT; Decker AM; Langston TL; Mathews KM; Laudermilk L; Maitra R; Ma W; Darcq E; Kieffer BL; Jin C
    J Med Chem; 2020 Dec; 63(23):14989-15012. PubMed ID: 33205975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Amide Bioisosteres Leading to 1,2,3-Triazole Containing Compounds as GPR88 Agonists: Design, Synthesis, and Structure-Activity Relationship Studies.
    Rahman MT; Decker AM; Laudermilk L; Maitra R; Ma W; Ben Hamida S; Darcq E; Kieffer BL; Jin C
    J Med Chem; 2021 Aug; 64(16):12397-12413. PubMed ID: 34387471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Orphan Receptor GPR88 as an Emerging Neurotherapeutic Target.
    Ye N; Li B; Mao Q; Wold EA; Tian S; Allen JA; Zhou J
    ACS Chem Neurosci; 2019 Jan; 10(1):190-200. PubMed ID: 30540906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and pharmacological evaluation of 4-hydroxyphenylglycine and 4-hydroxyphenylglycinol derivatives as GPR88 agonists.
    Jin C; Decker AM; Langston TL
    Bioorg Med Chem; 2017 Jan; 25(2):805-812. PubMed ID: 27956039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased Alcohol Seeking in Mice Lacking Gpr88 Involves Dysfunctional Mesocorticolimbic Networks.
    Ben Hamida S; Mendonça-Netto S; Arefin TM; Nasseef MT; Boulos LJ; McNicholas M; Ehrlich AT; Clarke E; Moquin L; Gratton A; Darcq E; Harsan LA; Maldonado R; Kieffer BL
    Biol Psychiatry; 2018 Aug; 84(3):202-212. PubMed ID: 29580570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, pharmacological characterization, and structure-activity relationship studies of small molecular agonists for the orphan GPR88 receptor.
    Jin C; Decker AM; Huang XP; Gilmour BP; Blough BE; Roth BL; Hu Y; Gill JB; Zhang XP
    ACS Chem Neurosci; 2014 Jul; 5(7):576-87. PubMed ID: 24793972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, Synthesis, and Structure-Activity Relationship Studies of Novel GPR88 Agonists (4-Substituted-phenyl)acetamides Based on the Reversed Amide Scaffold.
    Rahman MT; Guan D; Chaminda Lakmal HH; Decker AM; Imler GH; Kerr AT; Harris DL; Jin C
    ACS Chem Neurosci; 2024 Jan; 15(1):169-192. PubMed ID: 38086012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and evaluation of phenylglycinols and phenyl amines as agonists of GPR88.
    Dzierba CD; Bi Y; Dasgupta B; Hartz RA; Ahuja V; Cianchetta G; Kumi G; Dong L; Aleem S; Fink C; Garcia Y; Green M; Han J; Kwon S; Qiao Y; Wang J; Zhang Y; Liu Y; Zipp G; Liang Z; Burford N; Ferrante M; Bertekap R; Lewis M; Cacace A; Grace J; Wilson A; Nouraldeen A; Westphal R; Kimball D; Carson K; Bronson JJ; Macor JE
    Bioorg Med Chem Lett; 2015 Apr; 25(7):1448-52. PubMed ID: 25690789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a high-throughput calcium mobilization assay for the orphan receptor GPR88.
    Decker AM; Gay EA; Mathews KM; Rosa TC; Langston TL; Maitra R; Jin C
    J Biomed Sci; 2017 Mar; 24(1):23. PubMed ID: 28347302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation and allosteric regulation of the orphan GPR88-Gi1 signaling complex.
    Chen G; Xu J; Inoue A; Schmidt MF; Bai C; Lu Q; Gmeiner P; Liu Z; Du Y
    Nat Commun; 2022 May; 13(1):2375. PubMed ID: 35501348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GPR88 in A2AR Neurons Enhances Anxiety-Like Behaviors.
    Meirsman AC; Robé A; de Kerchove d'Exaerde A; Kieffer BL
    eNeuro; 2016; 3(4):. PubMed ID: 27570825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Substitution on the Aniline Moiety of the GPR88 Agonist 2-PCCA: Synthesis, Structure-Activity Relationships, and Molecular Modeling Studies.
    Jin C; Decker AM; Harris DL; Blough BE
    ACS Chem Neurosci; 2016 Oct; 7(10):1418-1432. PubMed ID: 27499251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orphan receptor GPR88 as a potential therapeutic target for CNS disorders - an
    Garisetti V; Dhanabalan AK; Dasararaju G
    J Biomol Struct Dyn; 2024 Jun; 42(9):4745-4758. PubMed ID: 37306437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping GPR88-Venus illuminates a novel role for GPR88 in sensory processing.
    Ehrlich AT; Semache M; Bailly J; Wojcik S; Arefin TM; Colley C; Le Gouill C; Gross F; Lukasheva V; Hogue M; Darcq E; Harsan LA; Bouvier M; Kieffer BL
    Brain Struct Funct; 2018 Apr; 223(3):1275-1296. PubMed ID: 29110094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of BI-9508, a Brain-Penetrant GPR88-Receptor-Agonist Tool Compound for
    Fer M; Amalric C; Arban R; Baron L; Ben Hamida S; Breh-Schlanser P; Cui Y; Darcq E; Eickmeier C; Faye V; Franchet C; Frauli M; Halter C; Heyer M; Hoenke C; Hoerer S; Hucke OT; Joseph C; Kieffer BL; Lebrun L; Lotz N; Mayer S; Omrani A; Recolet M; Schaeffer L; Schann S; Schlecker A; Steinberg E; Viloria M; Würstle K; Young K; Zinser A; Montel F; Klepp J
    J Med Chem; 2024 Jul; ():. PubMed ID: 38949964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The GPR88 receptor agonist 2-PCCA does not alter the behavioral effects of methamphetamine in rats.
    Li JX; Thorn DA; Jin C
    Eur J Pharmacol; 2013 Jan; 698(1-3):272-7. PubMed ID: 23123351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.